Atlas Trials

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Clinical trial NCT01552434 · TERMINATED

Trial details

NCT number
NCT01552434
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignant NeoplasmCastleman DiseaseDigestive System CarcinomaErdheim-Chester DiseaseLip and Oral Cavity CarcinomaLymphangioleiomyomatosisMalignant Endocrine NeoplasmMalignant Female Reproductive System NeoplasmMalignant Male Reproductive System NeoplasmMalignant NeoplasmMalignant Respiratory Tract NeoplasmMalignant Thoracic Neoplasm
Start date
2012-10-16
Primary completion
2026-05-08
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.